Underuse of Oral Anticoagulants in Privately Insured Patients with Atrial Fibrillation: A Population Being Targeted by the IMplementation of a Randomized Controlled Trial to ImProve Treatment with Oral AntiCoagulanTs in Patients with Atrial Fibrillation (IMPACT-AFib trial)

BACKGROUND: Although oral anticoagulants (OACs) have been shown to substantially reduce the risk of stroke and other thromboembolic events in patients with atrial fibrillation (AF), these medications are significantly underutilized in clinical practice. However, many studies showing underuse of OACs...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am Heart J
Main Authors: Al-Khatib, Sana M., Pokorney, Sean D., Al-Khalidi, Hussein R., Haynes, Kevin, Garcia, Crystal, Martin, David, Goldsack, Jennifer C., Harkins, Thomas, Cocoros, Noelle M., Lin, Nancy D., Lipowicz, Hana, McCall, Debbe, Nair, Vinit, Parlett, Lauren, Walraven, Cheryl, Platt, Richard, Granger, Christopher B.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8276627/
https://ncbi.nlm.nih.gov/pubmed/32949986
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ahj.2020.07.012
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados